SCHEMBL4876911

SCHEMBL4876911

COc1cccc(C2(COS(=O)(=O)c3ccc(C)cc3)CCN(c3ccccc3OC)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 6/20 0.52
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
HTR1A P08908 3/20 0.44
HTR7 P34969 2/20 0.44
HTR2A P28223 1/20 0.44
SLC6A4 P31645 1/20 0.44
HTR2B P41595 1/20 0.44
KCNH2 Q12809 1/20 0.44
KMT2A Q03164 2/20 0.43
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5469501 0.88 SOAT1 (0.53) SOAT1TP53POLBHTR1AHTR7
SCHEMBL5473580 0.87 SOAT1 (0.56) SOAT1TP53POLBHTR1AKMT2A
SCHEMBL4868372 0.85 SOAT1 (0.57) SOAT1HTR1AHTR7HTR2ASLC6A4
SCHEMBL5469635 0.83 SOAT1 (0.59) SOAT1HTR1AHTR7ADRA1DADRA1A
SCHEMBL5465635 0.81 SOAT1 (0.57) SOAT1HTR1AHTR7ADRA1DADRA1A
SCHEMBL5483383 0.79 SOAT1 (0.60) SOAT1HTR1AHTR7ADRA1DADRA1A
SCHEMBL4876624 0.79 SOAT1 (0.62) SOAT1HTR1AHTR7ADRA1DADRA1A
SCHEMBL14520369 0.79 SOAT1 (0.55) SOAT1HTR1AHTR7ADRA1DADRA1A
SCHEMBL5466317 0.79 SOAT1 (0.57) SOAT1HTR1AHTR7ADRA1DADRA1A
SCHEMBL4879267 0.79 SOAT1 (0.62) SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
US-20070078120-A1 Novel piperidine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-04-05 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed
EP-1679069-A1 NOVEL PIPERIDINE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 SOAT1 502/4885TP53 4043/4885POLB 4311/4885
US-20070078120-A1 Novel piperidine derivative LDLR, PRMT5, MSR1 SOAT1 1040/4885TP53 4462/4885POLB 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.